Elekta AB (MEX:EKTAB N) EBIT: MXN238 Mil (TTM As of Apr. 2026)


MEX:EKTAB N Elekta AB MEX:EKTAB N
79 GF Score
Price MXN126.63
GF Value MXN158.57
! 6 Warning Signs
View Full Analysis

What is Elekta AB EBIT?

Elekta AB MEX:EKTAB N 79 EBIT is MXN238 Mil as of Apr. 2026. GuruFocus rates MEX:EKTAB N with a GF Score™ of 79/100 and a GF Value™ of MXN158.57. The stock has 6 warning signs investors should review.

Elekta AB's earnings before interest and taxes (EBIT) for the three months ended in Apr. 2026 was MXN-990 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2026 was MXN238 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Elekta AB's annualized ROC % for the quarter that ended in Apr. 2026 was -7.73%. Elekta AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was -127.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Elekta AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 0.49%.


Elekta AB  (MEX:EKTAB N) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Elekta AB's annualized ROC % for the quarter that ended in Apr. 2026 is calculated as:

ROC % (Q: Apr. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2026 ) + Invested Capital (Q: Apr. 2026 ))/ count )
=-3960.96 * ( 1 - 0% )/( (51366.312 + 51095.633)/ 2 )
=-3960.96/51230.9725
=-7.73 %

where

Invested Capital(Q: Jan. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=52828.358 - 2842.02 - ( 4849.948 - max(0, 26250.033 - 24870.059+4849.948))
=51366.312

Invested Capital(Q: Apr. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=50938.782 - 3548.99 - ( 6026.48 - max(0, 28465.623 - 24759.782+6026.48))
=51095.633

Note: The Operating Income data used here is four times the quarterly (Apr. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Elekta AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2026  Q: Apr. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3960.96/( ( (3101.6 + max(-9400.235, 0)) + (3097.335 + max(-10029.015, 0)) )/ 2 )
=-3960.96/( ( 3101.6 + 3097.335 )/ 2 )
=-3960.96/3099.4675
=-127.79 %

where Working Capital is:

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7199.529 + 5762.295 + -1.9089999999997) - (2842.02 + 0 + 19518.13)
=-9400.235

Working Capital(Q: Apr. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6969.476 + 5434.982 + -1.8889999999992) - (3548.99 + 0 + 18882.594)
=-10029.015

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Elekta AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Apr. 2026 )
=238.006/48718.672
=0.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elekta AB EBIT Related Terms


Elekta AB EBIT Historical Data

* Premium members only.

The historical data trend for Elekta AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elekta AB EBIT Chart

Elekta AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,512.27 2,621.19 3,198.02 1,805.03 190.87

Elekta AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -306.86 383.87 724.13 120.25 -990.24

MEX:EKTAB N vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Elekta AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Elekta AB's EV-to-EBIT falls into.


MEX:EKTAB N
79GF Score
Elekta AB MEX:EKTAB N
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elekta AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN238 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN238 Mil mean?
Elekta AB (MEX:EKTAB N) has a EBIT of MXN238 Mil as of Apr. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Elekta AB.
Is Elekta AB's EBIT too high?
Elekta AB's current EBIT is MXN238 Mil. Overall, Elekta AB has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's EBIT compare to ABT and SYK?
Elekta AB's EBIT of MXN238 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Elekta AB. Elekta AB's current EBIT is MXN238 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Elekta AB (MEX:EKTAB N) has a current EBIT of MXN238 Mil. The stock's GF Value™ is MXN158.57, compared to a current price of MXN126.63 — trading 20.1% below its estimated fair value. The current EBIT is MXN238 Mil. Elekta AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Elekta AB (MEX:EKTAB N), the current EBIT is MXN238 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elekta AB (MEX:EKTAB N) Overvalued in 2026?

Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued. The current stock price of MXN126.63 is trading 20.1% below its estimated GF Value™ of MXN158.57.

Key valuation signals for MEX:EKTAB N:

  • EBIT: MXN238 Mil
  • GF Value™: MXN158.57 vs. price of MXN126.63 (20.1% below fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the MEX:EKTAB N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elekta AB Business Description

Address Hagaplan 4, Box 7593, Stockholm, SWE, 11368
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
79GF Score

Get the complete analysis for MEX:EKTAB N

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN126.63
Price
MXN158.57
GF Value